These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12692974)

  • 21. The structure of a β
    Iadanza MG; Silvers R; Boardman J; Smith HI; Karamanos TK; Debelouchina GT; Su Y; Griffin RG; Ranson NA; Radford SE
    Nat Commun; 2018 Oct; 9(1):4517. PubMed ID: 30375379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired lysosomal processing of beta2-microglobulin by infiltrating macrophages in dialysis amyloidosis.
    García-García M; Argilés ; Gouin-Charnet A; Durfort M; García-Valero J; Mourad G
    Kidney Int; 1999 Mar; 55(3):899-906. PubMed ID: 10027926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. beta(2)-microglobulin: from physiology to amyloidosis.
    Heegaard NH
    Amyloid; 2009; 16(3):151-73. PubMed ID: 19657763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta(2)-microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro.
    Kad NM; Thomson NH; Smith DP; Smith DA; Radford SE
    J Mol Biol; 2001 Oct; 313(3):559-71. PubMed ID: 11676539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-2-microglobulin: a possible new uremic toxin?
    Gejyo F; Brancaccio D
    Int J Artif Organs; 1988 Jan; 11(1):3-5. PubMed ID: 3283056
    [No Abstract]   [Full Text] [Related]  

  • 26. Lysine 58-cleaved beta2-microglobulin is not detectable by 2D electrophoresis in ex vivo amyloid fibrils of two patients affected by dialysis-related amyloidosis.
    Giorgetti S; Stoppini M; Tennent GA; Relini A; Marchese L; Raimondi S; Monti M; Marini S; Østergaard O; Heegaard NH; Pucci P; Esposito G; Merlini G; Bellotti V
    Protein Sci; 2007 Feb; 16(2):343-9. PubMed ID: 17242436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth of beta(2)-microglobulin-related amyloid fibrils by non-esterified fatty acids at a neutral pH.
    Hasegawa K; Tsutsumi-Yasuhara S; Ookoshi T; Ohhashi Y; Kimura H; Takahashi N; Yoshida H; Miyazaki R; Goto Y; Naiki H
    Biochem J; 2008 Dec; 416(2):307-15. PubMed ID: 18637792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pathogenesis of dialysis amyloidosis].
    Gejyo F; Hasegawa S; Homma N; Maruyama H; Maruyama S; Arakawa M
    Nihon Rinsho; 1992 Jan; 50 Suppl():796-800. PubMed ID: 1578769
    [No Abstract]   [Full Text] [Related]  

  • 29. Seeding-dependent propagation and maturation of amyloid fibril conformation.
    Yamaguchi K; Takahashi S; Kawai T; Naiki H; Goto Y
    J Mol Biol; 2005 Sep; 352(4):952-60. PubMed ID: 16126222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wild type beta-2 microglobulin and DE loop mutants display a common fibrillar architecture.
    Natalello A; Relini A; Penco A; Halabelian L; Bolognesi M; Doglia SM; Ricagno S
    PLoS One; 2015; 10(3):e0122449. PubMed ID: 25803608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increase in the conformational flexibility of beta 2-microglobulin upon copper binding: a possible role for copper in dialysis-related amyloidosis.
    Villanueva J; Hoshino M; Katou H; Kardos J; Hasegawa K; Naiki H; Goto Y
    Protein Sci; 2004 Mar; 13(3):797-809. PubMed ID: 14767076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New aspects in the pathogenesis of dialysis-related amyloidosis: pathophysiology of advanced glycation end products in renal failure.
    Miyata T
    Nihon Jinzo Gakkai Shi; 1996 May; 38(5):191-7. PubMed ID: 8699608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electron-microscopic and immunohistochemical study of beta-2-microglobulin-related amyloidosis.
    Nishi S; Ogino S; Maruyama Y; Honma N; Gejyo F; Morita T; Arakawa M
    Nephron; 1990; 56(4):357-63. PubMed ID: 1706823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomics of beta2-microglobulin amyloid fibrils.
    Stoppini M; Mangione P; Monti M; Giorgetti S; Marchese L; Arcidiaco P; Verga L; Segagni S; Pucci P; Merlini G; Bellotti V
    Biochim Biophys Acta; 2005 Nov; 1753(1):23-33. PubMed ID: 16154394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small molecule-mediated inhibition of β-2-microglobulin-based amyloid fibril formation.
    Marcinko TM; Dong J; LeBlanc R; Daborowski KV; Vachet RW
    J Biol Chem; 2017 Jun; 292(25):10630-10638. PubMed ID: 28468825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of heparin on conformation of the β2-microglobulin molecule.
    Uji Y; Motomiya Y; Ando Y
    Ther Apher Dial; 2012 Apr; 16(2):159-62. PubMed ID: 22458395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Limited proteolysis in the investigation of beta2-microglobulin amyloidogenic and fibrillar states.
    Monti M; Amoresano A; Giorgetti S; Bellotti V; Pucci P
    Biochim Biophys Acta; 2005 Nov; 1753(1):44-50. PubMed ID: 16213198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistence of beta 2-microglobulin amyloid 10 years after renal transplantation.
    Kessler M; Aymard B; Pourel J
    Nephrol Dial Transplant; 1994; 9(3):333-4. PubMed ID: 8052450
    [No Abstract]   [Full Text] [Related]  

  • 39. Alpha 2-macroglobulin protects some of the protein constituents of dialysis-associated amyloidosis from protease degradation.
    Gouin-Charnet A; Mourad G; Argilés A
    Biochem Biophys Res Commun; 1997 Feb; 231(1):48-51. PubMed ID: 9070217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the single disulphide bond of beta(2)-microglobulin in amyloidosis in vitro.
    Smith DP; Radford SE
    Protein Sci; 2001 Sep; 10(9):1775-84. PubMed ID: 11514668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.